Research Associate, Formulation Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Elektrofi · 2 days ago

Research Associate, Formulation Development

Elektrofi is a biotech company focused on revolutionizing the delivery of biologic therapies. They are seeking a motivated Research Associate in Formulation Development to support their Hypercon™ formulation platform, contributing to drug product development and optimizing formulations for therapeutic biologics.

Alternative MedicineBiotechnologyTherapeutics
badNo H1Bnote

Responsibilities

Contribute to drug product development activities to formulate a wide range of therapeutic biologic modalities into our proprietary Hypercon™ suspension using QbD principles
Utilize scaled-down process models and stress conditions to select formulations that optimize drug product performance, including protein stability and suspension physical properties
Exercise technical discretion in day-to-day laboratory activities
Manage, compile and analyze data using analytical software
Contribute to continuous improvement of systems and processes to improve workflow efficiency
Manage relevant method protocols, present findings and author reports

Qualification

Protein formulationsStatistical methodsTangential flow filtrationAseptic handling techniquesAnalytical softwareLaboratory skillsMS OfficeElectronic lab notebooksOrganizational skillsAttention to detailTeamwork

Required

Bachelors with 0+ years experience in Pharmaceutical Sciences, Chemical Engineering, Biochemistry, Bioengineering, Pharmaceutical Engineering, or a related field
Knowledge of protein formulations and degradation mechanisms
Knowledge of statistical methods and design of experiments methodology
Demonstrated good laboratory skills, organizational skills, and attention to detail
Ability to work in multi-disciplinary teams

Preferred

Hands-on experience with tangential flow filtration (TFF) of protein solutions and aseptic handling techniques is desirable
Familiarity with standard office software (MS Office, Teams, SharePoint, JMP) and electronic laboratory notebooks

Company

Elektrofi

twittertwittertwitter
company-logo
Elektrofi develops hyper concentration microparticle technology for subcutaneous biologic medicine delivery.

Funding

Current Stage
Growth Stage
Total Funding
$154.11M
Key Investors
National Science Foundation
2025-10-01Acquired
2024-08-22Series C· $112.25M
2022-06-13Series B· $40M

Leadership Team

leader-logo
Victoria Sluzky
Chief Technology Officer
linkedin
Company data provided by crunchbase